NOX4 and familial dilated cardiomyopathy: Another study also showed that inhibition of NOX signaling pathway could reduce myocardial oxidative damage by regulating the interaction of NOX2, NOX4 and ROS, thereby acting as a potential therapeutic target for the prevention and treatment of DCM [78] (Figure 2).